Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis

by Oidov Baatarkhuu, Hye Won Lee, Jacob George, Dashchirev Munkh-Orshikh, Baasankhuu Enkhtuvshin, Sosorbaram Ariunaa, Mohammed Eslam, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim
Published 2017-06-01

Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients

by Shih-Jer Hsu, Sukhee Enkhzaya, You-Yu Lin, Tai-Chung Tseng, Tulgaa Khosbayar, Cheng-Hsueh Tsai, Tzu-San Wang, Damba Enkhtuya, Dogsom Ivshinkhorol, Nyamsuren Naranzul, Badarch Jargalsaikhan, Jazag Amarsanaa, Oidov Baatarkhuu, Jia-Horng Kao
Published 2020-03-01

Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study

by Oidov Baatarkhuu, Jae Seung Lee, Jazag Amarsanaa, Do Young Kim, Sang Hoon Ahn, Nyamsuren Naranzul, Damba Enkhtuya, Nagir Choijamts, Purev Batbayar, Radnaa Otgonbayar, Bat-Ulzii Saruul, Chuluunbaatar Gantuul, Baljinnyam Gegeebadrakh, Narangerel Tuvshinbayar, Dorjgotov Badamsuren, Galsan Ulzmaa, Jamiyandorj Otgonbold, Kwang-Hyub Han
Published 2021-01-01